NeuroSense Therapeutics Ltd. announced that management will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026. Executives will conduct one-on-one meetings with investors to discuss the company's ongoing clinical developments and strategic outlook.
NeuroSense announced participation in a healthcare conference, a routine corporate event with no expected material impact on the stock.